Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes
Authors:
- Marie GueudinMGMarie Gueudin
- Jean Christophe PlantierJPJean Christophe Plantier
- Véronique LeméeVLVéronique Lemée
- Marie Paule SchmittMSMarie Paule Schmitt
- Loic ChartierLCLoic Chartier
- Thomas BourletTBThomas Bourlet
- Annick RuffaultARAnnick Ruffault
- Florence DamondFDFlorence Damond
- Muriel VrayMVMuriel Vray
- François SimonFSFrançois Simon
- 15 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 44 (5) , 500-505
Abstract
We conducted a comparison of the Abbott Molecular RealTime (Rungis, France) and Roche Diagnostics Cobas Taqman (Meylan, France) automated nucleic acid extraction and real-time polymerase chain reaction (PCR) amplification systems for their capacity to quantify HIV RNA of various subtypes. The systems were tested on culture supernatants belonging to HIV-1 group M (n = 29), HIV-1 group O (n = 8), and HIV-2 (n = 7). We also tested 88 plasma samples from patients infected with HIV-1 group M (B-D [n = 7], A-CRF01 [n = 16], CRF02 [n = 49], and other strains [n = 16]). The Abbott RealTime system quantified all 29 HIV-1 group M supernatants. One of these samples was not detected by the Roche Cobas TaqMan system. The Abbott RealTime system quantified 7 HIV-1 group O strains. Neither technique cross-reacted with HIV-2. The 79% intraclass correlation coefficient for the 88 plasma samples was barely acceptable, but 4 plasma samples were underestimated by more than 1 log by the Roche Cobas TaqMan system. Similar values were obtained for subtype B and D strains with the tests, indicating that the primers and probes are suitable for these strains. In contrast, the large differences observed with other subtypes, particularly CRF02, show the importance of primer and probe selection. The limitation of real-time PCR to span the entire diversity of HIV must be taken into account during treatment monitoring, resistance studies, and clinical trials.Keywords
This publication has 7 references indexed in Scilit:
- Plasma viral RNA assay in HIV-1 group O infection by real-time PCRJournal of Virological Methods, 2003
- Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B InfectionsJournal of Clinical Microbiology, 2002
- HIV-1 subtypes and plasma RNA quantificationAIDS, 1999
- Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysesJournal of Virology, 1997
- Comparing methods of measurement: why plotting difference against standard method is misleadingThe Lancet, 1995
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986